Spots Global Cancer Trial Database for sham
Every month we try and update this database with for sham cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia | NCT02336282 | Acute Lymphobla... | transcranial Di... Sham Cognitive Asses... Brain Games Sti... | 18 Years - | St. Jude Children's Research Hospital | |
| Remote Ischemic Preconditioning in Head and Neck Cancer Reconstruction - A Randomized Controlled Trial | NCT02548377 | Head and Neck N... | Remote ischemic... Sham | 18 Years - | Aarhus University Hospital Skejby | |
| Effects of VNS on RT-induced Inflammation and Prognosis of Patients With NSCLC | NCT03553485 | Lung Cancer, No... | Transcutaneous ... Sham Radiotherapy | 18 Years - | Vrije Universiteit Brussel | |
| Laser Treatment of Genito-urinary Syndrome in Women | NCT03238053 | Laser-Induced S... Breast Cancer Endometrial Can... Menopause Vaginal Atrophy Bladder, Overac... | Vaginal laser t... sham laser system | - | Herning Hospital | |
| A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) | NCT05850520 | Macular Edema S... | Aflibercept, VE... Aflibercept, VE... Sham Fluorescein | 18 Years - | Bayer | |
| Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) | NCT00943072 | Macular Edema S... | VEGF Trap-Eye 2... Sham | 18 Years - | Regeneron Pharmaceuticals | |
| ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of Pain | NCT00656305 | Bone Metastases Multiple Myelom... | ExAblate MRfFUS Sham | 18 Years - 100 Years | InSightec | |
| Effects of VNS on RT-induced Inflammation and Prognosis of Patients With NSCLC | NCT03553485 | Lung Cancer, No... | Transcutaneous ... Sham Radiotherapy | 18 Years - | Vrije Universiteit Brussel | |
| Treatment Of Radiation Retinopathy Trial | NCT00811200 | Uveal Melanoma | ranibizumab triamcinolone a... sham | 18 Years - | Leiden University Medical Center | |
| ESP Block for Laparoscopic Nephrectomy Surgeries | NCT04085237 | Kidney Cancer Post-surgical P... | Ropivacaine inj... Sham | 18 Years - | McMaster University | |
| Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) | NCT00943072 | Macular Edema S... | VEGF Trap-Eye 2... Sham | 18 Years - | Regeneron Pharmaceuticals | |
| A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) | NCT05850520 | Macular Edema S... | Aflibercept, VE... Aflibercept, VE... Sham Fluorescein | 18 Years - | Bayer |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
